Oct 4 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Friday it will discontinue a mid-stage field study of its experimental pill for prevention of dengue as the drugmaker reprioritized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback